Homeopathic medical practice: Long-term results of a cohort study with 3981 patients

Witt, Claudia M.; Lüdtke, Rainer; Baur, Roland; Willich, Stefan N.
January 2005
BMC Public Health;2005, Vol. 5 Issue 1, p115
Academic Journal
Background: On the range of diagnoses, course of treatment, and long-term outcome in patients who chose to receive homeopathic medical treatment very little is known. We investigated homeopathic practice in an industrialized country under everyday conditions. Methods: In a prospective, multicentre cohort study with 103 primary care practices with additional specialisation in homeopathy in Germany and Switzerland, data from all patients (age >1 year) consulting the physician for the first time were observed. The main outcome measures were: Patient and physician assessments (numeric rating scales from 0 to 10) and quality of life at baseline, and after 3, 12, and 24 months. Results: A total of 3,981 patients were studied including 2,851 adults (29% men, mean age 42.5 ± 13.1 years; 71% women, 39.9 ± 12.4 years) and 1,130 children (52% boys, 6.5 ± 3.9 years; 48% girls, 7.0 ± 4.3 years). Ninety-seven percent of all diagnoses were chronic with an average duration of 8.8 ± 8 years. The most frequent diagnoses were allergic rhinitis in men, headache in women, and atopic dermatitis in children. Disease severity decreased significantly (p < 0.001) between baseline and 24 months (adults from 6.2 ± 1.7 to 3.0 ± 2.2; children from 6.1 ± 1.8 to 2.2 ± 1.9). Physicians' assessments yielded similar results. For adults and young children, major improvements were observed for quality of life, whereas no changes were seen in adolescents. Younger age and more severe disease at baseline were factors predictive of better therapeutic success. Conclusion: Disease severity and quality of life demonstrated marked and sustained improvements following homeopathic treatment period. Our findings indicate that homeopathic medical therapy may play a beneficial role in the long-term care of patients with chronic diseases.


Related Articles

  • Evidence-based laboratory medicine – a guide for critical evaluation of in vitro laboratory testing. Christenson, Robert H. // Annals of Clinical Biochemistry;Mar2007, Vol. 44 Issue 2, p111 

    Evidence-based laboratory medicine (EBLM) is an essential part of modern laboratory medicine practice. This review presents a guide for better understanding and implementing the EBLM process. The process of EBLM begins with development of a clinically relevant question. Tools for assisting in...

  • Peginterferon Alfa-2a for AIDS-Associated Kaposi Sarcoma: Experience With 10 Patients. Rokx, Casper; van der Ende, Marchina E.; Verbon, Annelies; Rijnders, Bart J. A. // Clinical Infectious Diseases;Nov2013, Vol. 57 Issue 10, p1497 

    In this observational cohort study, 10 patients with extensive or treatment-refractory AIDS-associated Kaposi sarcoma were treated with peginterferon alfa-2a. Tumor responses were observed in 9 patients with a median progression-free survival of 645 days. Peginterferon alfa-2a could be an...

  • CORRECTION.  // Contemporary OB/GYN;Dec2002, Vol. 47 Issue 12, p26 

    Presents a correction to the article "Cohort and Case-Control Studies: Forward and Backward in Clinical Research," that was previously published in the October 2002 issue of "Contemporary OB/GYN."

  • ALLOPATHY and HOMOEOPATHY CONTRASTED. Sweeney, Edward J. // Journal of Civil War Medicine;Jan-Mar2012, Vol. 16 Issue 1, p1 

    A reprint of the 1863 medical pamphlet "Allopathy and Homoeopathy Contrasted," by Homoeopathic doctor Edward J. Sweeney is presented. The author contrasts the allopathic and homoeopathic medical treatment and contends that the latter has a greater survival rate for illness than allopathic...

  • Practice Opportunity now Available.  // Homeopathy Today;Jul/Aug2006, Vol. 26 Issue 4, p7 

    The article reports on the availability of well-established practice with strong emphasis on homeopathy for immediate purchase. An integrative component is also available including the use of osteopathic manipulative medicine, bio-identical hormone therapy and nutritional support. This practice...

  • GLOSSARY.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, pA-19 

    The article clarifies the terms and terminologies used in the therapeutics and diagnosis. Further, the article also provides the definitions relating to data presentation in the therapeutics. The article adds that sensitivity is the proportion of patients with the target disorder who have a...

  • Fetal exposure to valproate was associated with lower IQ scores at 3 years of age than exposure to other antiepileptic drugs. Pinzon, Rizaldy // Evidence Based Medicine;Oct2009, Vol. 14 Issue 5, p21 

    The article provides insights on a study regarding the relationship between the fetal exposure to different antiepileptic drugs to different cognitive outcomes in children. A planned interim analysis of a prospective cohort study was conducted to 309 children whose mothers had epilepsy and were...

  • Bleeding, dyspnoea and discontinuation in a real world ACS cohort treated with ticagrelor. Harding, S.; Fairley, S.; Al-Sinan, A.; Holley, A.; Howard, C.; Matsis, P.; Aitken, A.; Larsen, P. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS376 

    No abstract available.

  • Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. Lévesque, Linda E.; Hanley, James A.; Kezouh, Abbas; Suissa, Samy // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/24/2010, Vol. 340 Issue 7752, p907 

    The article discusses the problem of immortal time bias in cohort studies with an example using statins for preventing progression of diabetes. It explains the notion of immortal time bias which refers to a period of follow-up during which death or the study outcome cannot occur. It describes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics